<Disease><Name>SCHINDLER DISEASE, TYPE I</Name><Synonym>ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY, TYPE I; SCHINDLER DISEASE, TYPE III, INCLUDED</Synonym><OMIM><Number>609241</Number><URL>http://omim.org/entry/609241</URL></OMIM><Orphanet><Number>3137</Number><URL>http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=EN&amp;Expert=3137</URL></Orphanet><Protein><Number>Alpha-N-acetylgalactosaminidase</Number><URL>http://www.uniprot.org/uniprot/P17050</URL></Protein><ExPASy><Number>3.2.1.49</Number><URL>http://enzyme.expasy.org/EC/3.2.1.49</URL></ExPASy><Gene>22q13.2</Gene><ICD>E77.1</ICD><Summary>rare ;autosomal recessive ;mutation in the alpha-N-acetylgalactosaminidase gene (NAGA);type I: Schindler disease, infantile onset neuroaxonal dystrophy ;type II:Kanzaki disease, adult-onset peripheral neuroaxonal degeneration, angiokeratoma corporis diffusum and mild intellectual impairment may present as a non-disease (present healthy case) [Bakker HD et al. 2001];type III: intermediate form</Summary><Symptoms><symtomp><id>2211</id><symptom>blindness, visual loss, visual impairment</symptom><category>EYES | NERVOUS SYSTEM</category></symtomp><symtomp><id>1736</id><symptom>cataract</symptom><category>EYES</category></symtomp><symtomp><id>1966</id><symptom>cerebellar atrophy or hypoplasia</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>2226</id><symptom>cerebral atrophy</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>2247</id><symptom>contractures, joints</symptom><category>GENERAL TOPICS | SKELETAL DEFECT</category></symtomp><symtomp><id>2117</id><symptom>CT, brain, abnormalities [-] / CT, kraniell, abnormal </symptom><category>LABORATORY FINDINGS</category></symtomp><symtomp><id>1895</id><symptom>decreased muscle volume, atrophy or hypoplasia</symptom><category>MUSCLES</category></symtomp><symtomp><id>3819</id><symptom>developmental delay</symptom><category>GENERAL TOPICS</category></symtomp><symtomp><id>2160</id><symptom>EEG abnormalities [-]</symptom><category>LABORATORY FINDINGS</category></symtomp><symtomp><id>3709</id><symptom>epilepsy</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>2261</id><symptom>hyperreflexia</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>1897</id><symptom>hypotonia</symptom><category>MUSCLES | NERVOUS SYSTEM</category></symtomp><symtomp><id>2424</id><symptom>mental retardation</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>1941</id><symptom>motor retardation / motor developmental delay</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>2213</id><symptom>MRI, brain, abnormalities [-]</symptom><category>LABORATORY FINDINGS | NERVOUS SYSTEM</category></symtomp><symtomp><id>1900</id><symptom>myoclonus</symptom><category>MUSCLES | NERVOUS SYSTEM</category></symtomp><symtomp><id>1917</id><symptom>neurological deterioration / neurologic deterioration</symptom><category>GENERAL TOPICS | NERVOUS SYSTEM</category></symtomp><symtomp><id>2340</id><symptom>normal at birth</symptom><category>GENERAL TOPICS</category></symtomp><symtomp><id>1723</id><symptom>nystagmus</symptom><category>EYES | NERVOUS SYSTEM</category></symtomp><symtomp><id>2507</id><symptom>onset, childhood / childhood</symptom><category>GENERAL TOPICS</category></symtomp><symtomp><id>2505</id><symptom>onset, infancy / infancy</symptom><category>GENERAL TOPICS</category></symtomp><symtomp><id>1739</id><symptom>optic atrophy</symptom><category>EYES | NERVOUS SYSTEM</category></symtomp><symtomp><id>1943</id><symptom>seizures</symptom><category>NERVOUS SYSTEM | NERVOUS SYSTEM</category></symtomp><symtomp><id>2173</id><symptom>strabismus</symptom><category>EYES</category></symtomp></Symptoms><Metabolites><metabolite><id>1085</id><name>alpha-N-Acetylgalactosaminidase</name><specimen>plasma</specimen><value>decreased</value><min>10.70</min><max>28.50</max><unit>nmol/h/ml</unit><age>no data</age><method /><comment /></metabolite><metabolite><id>1086</id><name>alpha-N-Acetylgalactosaminidase</name><specimen>fibroblasts</specimen><value>decreased</value><min>94.30</min><max>260.00</max><unit>nmol/h/mg protein</unit><age>no data</age><method /><comment /></metabolite><metabolite><id>1087</id><name>alpha-N-Acetylgalactosaminidase</name><specimen>lymphoblasts</specimen><value>decreased</value><min>21.70</min><max>62.90</max><unit>nmol/h/mg protein</unit><age>no data</age><method /><comment /></metabolite><metabolite><id>1088</id><name>Glycopeptides</name><specimen>urine</specimen><value>increased</value><min>    </min><max>    </max><unit>not detectable</unit><age>no data</age><method /><comment /></metabolite><metabolite><id>965</id><name>Oligosaccharides</name><specimen>urine</specimen><value>increased</value><min>    </min><max>    </max><unit>not detectable</unit><age>no data</age><method /><comment /></metabolite></Metabolites><Literatures><literature><id>3607</id><title>Application of ion mobility tandem mass spectrometry to compositional and structural analysis of glycopeptides extracted from t</title><author>Sarbu M,</author><journal>Rapid Commun Mass Spectrom</journal><year>2015</year><book /><volume>29</volume><number>21</number><pages>1929-1937</pages><co_aut>et al.</co_aut></literature><literature><id>3608</id><title>Automated chip-nanoelectrospray mass spectrometry for glycourinomics in Schindler disease type I</title><author>Sarbu M,</author><journal>Carbohydr Res</journal><year>2014</year><book /><volume>398</volume><number>0</number><pages>90-100</pages><co_aut>et al.</co_aut></literature><literature><id>2912</id><title>The 1.9 A structure of human alpha-N-acetylgalactosaminidase: The molecular basis of Schindler and Kanzaki diseases</title><author>Clark NE</author><journal>J Mol Biol</journal><year>2009</year><book /><volume>0</volume><number>0</number><pages /><co_aut>Garman SC</co_aut></literature><literature><id>1620</id><title>Structural and immunocytochemical studies on alpha-N-acetylgalactosaminidase deficiency (Schindler/Kanzaki disease</title><author>Sakuraba H</author><journal>J Hum Genet</journal><year>2004</year><book /><volume>49</volume><number>1</number><pages>1-8</pages><co_aut>et al.</co_aut></literature><literature><id>1232</id><title>Human alpha-N-acetylgalactosaminidase (alpha-NAGA) deficiency: no association with neuroaxonal dystrophy?</title><author>Bakker HD</author><journal>Eur J Hum Genet</journal><year>2001</year><book /><volume>9</volume><number>2</number><pages>91-96</pages><co_aut>et al.</co_aut></literature><literature><id>399</id><title>alpha-N-Acetylgalactosaminidase deficiency: Schindler disease</title><author>Desnick RJ</author><journal>The metabolic and molecular bases of inherited disease, 7/e; Editors: C.R.Scriver, A.L.Beaudet, W.S.Sly, D.Valle; McGraw-Hill Inc.</journal><year>1995</year><book /><volume>2</volume><number>0</number><pages>2509-2528</pages><co_aut>Wang AM</co_aut></literature><literature><id>404</id><title>Neuroaxonal dystrophy in infantile alpha-N-acetylgalactosaminidase deficiency</title><author>Wolfe DE</author><journal>J Neurol Sci</journal><year>1995</year><book /><volume>132</volume><number>0</number><pages>44-56</pages><co_aut>Schindler D, Desnick RJ</co_aut></literature><literature><id>1619</id><title>Schindler disease/Kanzaki disease</title><author>Kanzaki T</author><journal>Nippon Rinsho</journal><year>1995</year><book /><volume>53</volume><number>12</number><pages>2982-2987</pages><co_aut /></literature><literature><id>400</id><title>Alpha-N-acetylgalactosaminidase deficiency with mild clinical manifestation and difficult biochemical diagnosis</title><author>de Jong J</author><journal>J Pediatr</journal><year>1994</year><book /><volume>125</volume><number>0</number><pages>385-391</pages><co_aut>et al.</co_aut></literature><literature><id>397</id><title>Neuroaxonal dystrophy due to lysosomal alpha-N-acetylgalactosaminidase deficiency</title><author>Schindler D</author><journal>N Engl J Med</journal><year>1989</year><book /><volume>320</volume><number>0</number><pages>1735</pages><co_aut>et al.</co_aut></literature><literature><id>2916</id><title>Neuroaxonal dystrophy due to lysosomal alpha-N-acetylgalactosaminidase deficiency</title><author>Schindler D</author><journal>N Engl J Med</journal><year>1989</year><book /><volume>320</volume><number>26</number><pages>1735-1740</pages><co_aut>et al.</co_aut></literature><literature><id>398</id><title>Lysosomal alpha-N-acetylgalctosaminidase deficiency: a new inherited metabolic disease</title><author>van Diggelen OP</author><journal>Lancet II</journal><year>1987</year><book /><volume>0</volume><number>0</number><pages>804</pages><co_aut>Schindler D et al.</co_aut></literature></Literatures></Disease>